ARCH Venture Fund IX, L.P. SEC EDGAR Filings (CIK 0001666306)

SEC EDGAR filings, ownership reports, and insider transactions for ARCH Venture Fund IX, L.P..

Business address
8755 W. Higgins Road, Suite 1025, Chicago, IL, 60631
Top holdings (Schedule 13G)
SANA, BEAM, LYEL, and OMIC
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
ARCH Venture Fund IX, L.P. has filed 71 SEC EDGAR filings since 17 Mar 2016

Latest Filings

Recent SEC filings for ARCH Venture Fund IX, L.P. including SCHEDULE 13G/A, 4, CORRESP and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Nov 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Nov 2025
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 29 Jul 2025 25 Jul 2025 001-40502
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 15 May 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 15 May 2025
CORRESP Open CORRESP document View SEC filing for CORRESP 24 Feb 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Feb 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Feb 2025
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#3) 14 Nov 2024
SC 13D Open SC 13D document View SEC filing for SC 13D ARCH VENTURE FUND IX, L.P. - BOUNDLESS BIO -- SCH 13D 29 Oct 2024
4 Open 4 document View SEC filing for 4 4 04 Apr 2024 02 Apr 2024 001-41989
3 Open 3 document View SEC filing for 3 3 27 Mar 2024 27 Mar 2024 001-41989
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G/A(#1) 14 Feb 2024
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G/A(#2) 14 Feb 2024
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 12 Feb 2024 08 Feb 2024 001-39941
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#2) 09 Feb 2024
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO -- SCH 13G/A(#1-EXIT) 09 Feb 2024
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#1) 13 Feb 2023
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- KARUNA THERAPEUTICS -- SCHEDULE 13DA(4E) 20 Sep 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#6) 13 Sep 2022
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 07 Sep 2022 02 Sep 2022 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 01 Sep 2022 30 Aug 2022 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 26 Aug 2022 24 Aug 2022 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 22 Aug 2022 18 Aug 2022 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 16 Aug 2022 12 Aug 2022 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 10 Jun 2022 08 Jun 2022 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 06 Jun 2022 02 Jun 2022 001-39083
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#5) 10 May 2022
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G/A(#1) 14 Feb 2022
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND IX, L.P. - LYELL IMMUNOPHARMA -- SCH 13G 14 Feb 2022
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G 10 Feb 2022
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND IX, L.P. - SINGULAR GENOMICS SYSTEMS -- SCH 13G 04 Feb 2022
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#4) 10 Jan 2022
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 22 Dec 2021 20 Dec 2021 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 01 Dec 2021 29 Nov 2021 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 24 Nov 2021 22 Nov 2021 001-39083
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#3) 12 Jul 2021
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 06 Jul 2021 01 Jul 2021 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 02 Jul 2021 30 Jun 2021 001-39208
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 29 Jun 2021 25 Jun 2021 001-39208
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 24 Jun 2021 22 Jun 2021 001-39083
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 23 Jun 2021 21 Jun 2021 001-40502
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 16 Jun 2021 16 Jun 2021 001-40502
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- KARUNA THERAPEUTICS -- SCHEDULE 13DA(3) 23 Apr 2021
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 15 Apr 2021 13 Apr 2021 001-38958
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(#2) 14 Apr 2021
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 09 Apr 2021 07 Apr 2021 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 02 Apr 2021 31 Mar 2021 001-39208
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 01 Apr 2021 30 Mar 2021 001-39083
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 22 Mar 2021 18 Mar 2021 001-39208
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Feb 2021 08 Feb 2021 001-39941
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Feb 2021 03 Feb 2021 001-39941
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G 02 Feb 2021
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- KARUNA THERAPEUTICS -- SCHEDULE 13DA(2) 19 Jan 2021
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 12 Jan 2021 08 Jan 2021 001-38958
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 16 Nov 2020 12 Nov 2020 001-38958
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. -- VIR BIOTECHNOLOGY, INC. -- SCHEDULE 13DA(1) 29 Jul 2020
SC 13G Open SC 13G document View SEC filing for SC 13G ARCH VENTURE FUND IX, L.P. - GOSSAMER BIO, INC. -- SCHEDULE 13G 13 Feb 2020
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 11 Feb 2020 10 Feb 2020 001-39208
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 05 Feb 2020 05 Feb 2020 001-39208
SC 13D/A Open SC 13D/A document View SEC filing for SC 13D/A ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D/A(#1) - KARUNA THERAPEUTICS, INC. 13 Dec 2019
SC 13D Open SC 13D document View SEC filing for SC 13D ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D - VIR BIOTECHNOLOGY, INC. 08 Nov 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 18 Oct 2019 16 Oct 2019 001-39083
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 10 Oct 2019 10 Oct 2019 001-39083
SC 13D Open SC 13D document View SEC filing for SC 13D ARCH VENTURE FUND IX, L.P. - SCHEDULE 13D - KARUNA THERAPEUTICS, INC. 12 Jul 2019
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Jul 2019 02 Jul 2019 001-38958
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 27 Jun 2019 27 Jun 2019 001-38958
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 12 Feb 2019 12 Feb 2019 001-38796
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 07 Feb 2019 07 Feb 2019 001-38796
D/A Open D/A document View SEC filing for D/A 18 Nov 2016 021-259517
D Open D document View SEC filing for D 17 Mar 2016 021-259517

About this filer

ARCH Venture Fund IX, L.P. files with the SEC under CIK 0001666306. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages